This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
According to U.N. figures, more than 220 million people worldwide suffer from food allergies, which cause the body to perceive an otherwise harmless protein in food as dangerous. As a result, the immune system launches an attack on the protein, which in the worst cases can be life-threatening.
In the only treatment currently capable of potentially curing people's allergies, patients are exposed over several years—via injections or tablets—to increasing amounts of the protein (allergen) they cannot tolerate, so the body gradually gets used to it.
However, due to the hassle and discomfort of the treatment, many people choose "simply" to avoid the substances to which they are allergic, as well as anything that might trigger a cross-reaction.
As an alternative, researchers at DTU have developed a vaccine that contains a synthetic allergen. The allergen shares common features with several related and widespread allergens found, for example, in peaches and certain nuts.
The vaccine is designed to reprogram the body's immune system so that, upon encountering these related allergens, it produces protective antibodies that can recognize and block the allergens before they have a chance to trigger an allergic reaction.
"The idea is that if you are allergic to several different things, all of which have roughly the same molecular structure, we can take this structure and produce an artificial allergen, which we then incorporate into a vaccine," explains Associate Professor Esperanza Rivera de Torre from DTU Bioengineering.
Source link







